U.S. flag

An official website of the United States government

NM_004333.6(BRAF):c.1502A>G (p.Glu501Gly) AND Cardiofaciocutaneous syndrome 1

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Oct 2, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000015012.28

Allele description [Variation Report for NM_004333.6(BRAF):c.1502A>G (p.Glu501Gly)]

NM_004333.6(BRAF):c.1502A>G (p.Glu501Gly)

Gene:
BRAF:B-Raf proto-oncogene, serine/threonine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q34
Genomic location:
Preferred name:
NM_004333.6(BRAF):c.1502A>G (p.Glu501Gly)
Other names:
p.E501G:GAA>GGA
HGVS:
  • NC_000007.14:g.140778006T>C
  • NG_007873.3:g.151759A>G
  • NM_001354609.2:c.1502A>G
  • NM_001374244.1:c.1622A>G
  • NM_001374258.1:c.1622A>G
  • NM_001378467.1:c.1511A>G
  • NM_001378468.1:c.1502A>G
  • NM_001378469.1:c.1436A>G
  • NM_001378470.1:c.1400A>G
  • NM_001378471.1:c.1391A>G
  • NM_001378472.1:c.1346A>G
  • NM_001378473.1:c.1346A>G
  • NM_001378474.1:c.1502A>G
  • NM_001378475.1:c.1238A>G
  • NM_004333.6:c.1502A>GMANE SELECT
  • NP_001341538.1:p.Glu501Gly
  • NP_001361173.1:p.Glu541Gly
  • NP_001361187.1:p.Glu541Gly
  • NP_001365396.1:p.Glu504Gly
  • NP_001365397.1:p.Glu501Gly
  • NP_001365398.1:p.Glu479Gly
  • NP_001365399.1:p.Glu467Gly
  • NP_001365400.1:p.Glu464Gly
  • NP_001365401.1:p.Glu449Gly
  • NP_001365402.1:p.Glu449Gly
  • NP_001365403.1:p.Glu501Gly
  • NP_001365404.1:p.Glu413Gly
  • NP_004324.2:p.Glu501Gly
  • LRG_299t1:c.1502A>G
  • LRG_299:g.151759A>G
  • NC_000007.13:g.140477806T>C
  • NM_004333.4:c.1502A>G
  • P15056:p.Glu501Gly
  • c.1502A>G
Protein change:
E413G; GLU501GLY
Links:
UniProtKB: P15056#VAR_026117; OMIM: 164757.0018; dbSNP: rs180177039
NCBI 1000 Genomes Browser:
rs180177039
Molecular consequence:
  • NM_001354609.2:c.1502A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374244.1:c.1622A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001374258.1:c.1622A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378467.1:c.1511A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378468.1:c.1502A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378469.1:c.1436A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378470.1:c.1400A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378471.1:c.1391A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378472.1:c.1346A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378473.1:c.1346A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378474.1:c.1502A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378475.1:c.1238A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004333.6:c.1502A>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Cardiofaciocutaneous syndrome 1 (CFC1)
Synonyms:
Congenital heart defects characteristic facial appearance ectodermal abnormalities and growth failure
Identifiers:
MONDO: MONDO:0007265; MedGen: CN029449; Orphanet: 1340; OMIM: 115150

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000035268OMIM
no assertion criteria provided
Pathogenic
(Mar 1, 2006)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000143823Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP)
no classification provided
not providedgermlinenot provided

PubMed (1)
[See all records that cite this PMID]

SCV0020120613billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 2, 2021)
unknownclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot provided1not providedliterature only
not providedunknownyes1not providednot provided1not providedclinical testing

Citations

PubMed

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.

Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, Conger BA, Cruz MS, McCormick F, Rauen KA.

Science. 2006 Mar 3;311(5765):1287-90. Epub 2006 Jan 26.

PubMed [citation]
PMID:
16439621

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.

Niihori T, Aoki Y, Narumi Y, Neri G, Cavé H, Verloes A, Okamoto N, Hennekam RC, Gillessen-Kaesbach G, Wieczorek D, Kavamura MI, Kurosawa K, Ohashi H, Wilson L, Heron D, Bonneau D, Corona G, Kaname T, Naritomi K, Baumann C, Matsumoto N, Kato K, et al.

Nat Genet. 2006 Mar;38(3):294-6. Epub 2006 Feb 12.

PubMed [citation]
PMID:
16474404
See all PubMed Citations (5)

Details of each submission

From OMIM, SCV000035268.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 presumably unrelated patients with cardiofaciocutaneous syndrome (CFC1; 115150), Niihori et al. (2006) found a heterozygous 1502A-G transition in exon 12 of the BRAF gene, predicting a glu501-to-gly (E501G) amino acid change.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), SCV000143823.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot provided1not providednot providednot providednot providednot providednot provided

From 3billion, SCV002012061.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (4)

Description

Same nucleotide change resulting in same amino acid change has been previously reported multiple times as de novo in similarly affected indivisual (PMID: 1647440, 17366577, 17704260, PS2, PS4). The missense variant is located in a mutational hot spot and/or well-established functional domain in which established pathogenic variants have been reported (PM1). It is not observed in the gnomAD v2.1.1 dataset (PM2). A different missense change at the same codon (p.Glu501Lys and pGlu501Ala) has been reported as pathogenic (VCV000013977.4, VCV000040373.5, PM5). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.992, 3Cnet: 0.999, PP3). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyes1not providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024